(Q33732646)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

review article

1 reference

title

Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

R M Zusman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J H Chesebro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Comerota

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J R Hartmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E K Massin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E Raps

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P A Wolf

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

559-573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Cerebral ischemia and asymptomatic coronary artery disease: a prospective study of 83 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

The relation between systematic reviews and practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

New developments in antiplatelet and antithrombotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Antiplatelet therapy and the prevention of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Antiplatelet drugs. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Development of aspirin resistance in persons with previous ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Medical compared with surgical treatment of asymptomatic carotid artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Comparison of Effects of High-Dose and Low-Dose Aspirin on Restenosis After Femoropopliteal Percutaneous Transluminal Angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group

21 January 2018

1 reference

12 December 2020

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase

1 reference

12 December 2020

States of insulin resistance: the interaction between hypertension, glucose intolerance, and coronary heart disease. Proceedings of a symposium. Montreal, Canada, June 24, 1990

1 reference

12 December 2020

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group

1 reference

12 December 2020

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

1 reference

12 December 2020

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

12 December 2020

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

12 December 2020

A prospective study of aspirin use and primary prevention of cardiovascular disease in women

1 reference

12 December 2020

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

12 December 2020

Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications

1 reference

12 December 2020

Randomised trial of prophylactic daily aspirin in British male doctors

1 reference

12 December 2020

Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

The appropriateness of carotid endarterectomy

1 reference

12 December 2020

Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states

1 reference

12 December 2020

Basic data concerning associated coronary disease in peripheral vascular patients

1 reference

12 December 2020

The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group

1 reference

12 December 2020

Aspirin in coronary heart disease. The Coronary Drug Project Research Group

1 reference

12 December 2020

The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group

1 reference

12 December 2020

Primary prevention of stroke

1 reference

12 December 2020

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group

1 reference

12 December 2020

Clinical recommendations using levels of evidence for antithrombotic agents

1 reference

12 December 2020

Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects

1 reference

12 December 2020

Antithrombotic therapy in peripheral arterial occlusive disease

1 reference

12 December 2020

Antithrombotic therapy for cerebrovascular disorders. An update

1 reference

12 December 2020

1 reference

12 December 2020

Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis.

1 reference

12 December 2020

Platelets and Platelet Inhibitors in Acute Myocardial Infarction

1 reference

12 December 2020

Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories

1 reference

12 December 2020

Subclinical Disease as an Independent Risk Factor for Cardiovascular Disease

1 reference

12 December 2020

Pharmacokinetic optimisation of the treatment of embolic disorders

1 reference

12 December 2020

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study

1 reference

12 December 2020

Does aspirin consumption affect the presentation or severity of acute myocardial infarction?

1 reference

12 December 2020

Drugs and surgery in the prevention of ischemic stroke

1 reference

12 December 2020

Antithrombotic agents in cerebral ischemia

1 reference

12 December 2020

Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations

1 reference

12 December 2020

Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age.

1 reference

12 December 2020

Aspirin, platelets, and thrombosis: theory and practice.

1 reference

12 December 2020

Aspirin as an antiplatelet drug

1 reference

12 December 2020

The association of changes in physical-activity level and other lifestyle characteristics with mortality among men

1 reference

12 December 2020

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

1 reference

12 December 2020

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

12 December 2020

1 reference

12 December 2020

Ticlopidine or clopidogrel as alternatives to aspirin in prevention of ischemic stroke

1 reference

12 December 2020

Acute stroke therapies

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation

1 reference

12 December 2020

New thoughts on strategies for modulating platelet function through the inhibition of surface receptors

1 reference

12 December 2020

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

12 December 2020

Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group

1 reference

12 December 2020

A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly

1 reference

12 December 2020

Aspirin in the treatment and prevention of cardiovascular disease

1 reference

12 December 2020

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group

1 reference

12 December 2020

Antiplatelet effect of ticlopidine after coronary stenting

1 reference

12 December 2020

CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group

1 reference

12 December 2020

Practice guidelines and prediction rules should be subject to careful clinical testing

1 reference

12 December 2020

Evidence-based disease management

1 reference

12 December 2020

Detailed diagnoses and procedures, National Hospital Discharge Survey, 1995.

1 reference

12 December 2020

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

7 January 2021

inferred from DOI database lookup

Clinical Practice Guidelines – Directions for a New Program

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960220905

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CLC.4960220905

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PubMed publication ID

10486695

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10486695%20AND%20SRC:MED&resulttype=core&format=json